Tuesday, October 27, 2026
Noti Group
Health

Norwegian University Study Finds Anti-Inflammatory Medications May Facilitate Viral Spread

Researchers at the Norwegian University of Science and Technology have discovered that certain anti-inflammatory medications may inadvertently facilitate the spread of viruses through the body by suppressing key immune responses.

Common drugs may help dangerous viruses spread through the body
Source: ScienceDaily Health

Researchers have made a startling discovery about certain medications used to control inflammation in patients. These widely prescribed anti-inflammatory drugs may inadvertently facilitate the spread of viruses through the body.

The Norwegian University of Science and Technology has been investigating the effects of these medications on the immune system. According to findings from the university, a specific class of anti-inflammatory medications called Janus kinase inhibitors, or JAKs, could be making it easier for certain viruses to infect cells and move through the body.

Denis Kainov, a professor at NTNU's Department of Clinical and Molecular Medicine, emphasizes that this is an unexpected side effect. "We have found a surprising and potentially serious side effect of a class of anti-inflammatory drugs," he states. These medications are commonly prescribed for controlling inflammation but may leave the body more susceptible to viral infections.

The particular viruses that could be taking advantage of this vulnerability include Rift Valley fever virus, influenza A, adenovirus, and SARS-CoV-2, which causes COVID-19.

The study found that JAK inhibitors can weaken the body's defenses against viruses by suppressing certain immune responses.

One key consequence of this suppression is the disruption of a crucial immune signalling pathway that helps protect healthy cells from viral attacks. This pathway plays a central role in coordinating the body's response when viruses attempt to infect healthy tissue.

The research team discovered that JAK inhibitors can reduce the activity of genes involved in fighting viral infections, which are essential for the body's response to viral threats.

These genes help the immune system recognize and neutralize invading viruses, and their suppression by JAK inhibitors could make it easier for viruses to spread through the body.

When JAK inhibitors interfere with the immune system's signaling pathways, they compromise a critical layer of defense against viruses. This weakened state makes it easier for viruses to establish an infection and spread between cells.

To investigate these effects, researchers employed advanced virology methods in combination with gene expression analysis and organoid technology. They conducted experiments on cells from various human tissues, including the lungs, eyes, and brain, as well as miniature organ models grown in the laboratory.

These approaches allowed the team to examine how JAK inhibitors impact antiviral defenses across different types of human tissue. By using this multi-faceted approach, researchers gained a more comprehensive understanding of the drugs' effects on the immune system.

According to one researcher, Although JAK inhibitors are effective in treating inflammation, our findings suggest that they can pose a hidden risk for patients with latent or active viral infections. This warning highlights the need for caution when prescribing these medications during periods of increased viral transmission.

The study's results emphasize the importance of carefully weighing the benefits and risks associated with JAK inhibitors. Researchers recommend that healthcare professionals exercise discretion when prescribing these drugs, particularly in cases where patients may already have a viral infection or when outbreaks are occurring.

The study's findings highlight the need for healthcare professionals to exercise caution when prescribing certain medications that can inadvertently facilitate the spread of viral infections through the body.

Researchers suggest that further investigation is necessary to determine the safest and most effective uses of these drugs, particularly in situations where outbreaks are occurring or pandemics have been declared.

The study was made possible by the scientific expertise provided by Professor Magnar Bjørås and secured funding from various regional health authorities and research councils in Norway and Sweden.

These findings underscore the importance of careful consideration when prescribing medications that can impact the immune system, allowing viruses to spread more easily through the body.

Facts based on reporting originally published by ScienceDaily Health.

You may republish this story, in full or in part, if you credit Noti Group and link to it (licence CC BY 4.0). Photos are not included.